Department of Clinical Chemistry and Laboratory Medicine, Danube Hospital, Langobardenstr. 122, 1220 Vienna, Austria.
J Neural Transm (Vienna). 2012 Jan;119(1):77-80. doi: 10.1007/s00702-011-0667-9. Epub 2011 Jun 4.
The role of the CLSTN2 (rs6439886) and KIBRA (rs17070145) SNPs in cognitive impairment was analysed in a 75-76 years old group. Various memory assessment tests were carried out on individuals at baseline and during follow-up investigations, and biallelic genotyping was performed. No influence of the allele status of either SNPs was observed on any memory test. No increased risk of any type of late development, and cognitive impairment was associated with rs6439886 or rs17070145.
研究人员分析了 CLSTN2(rs6439886)和 KIBRA(rs17070145)单核苷酸多态性在 75-76 岁人群认知障碍中的作用。在研究开始和随访期间,对个体进行了各种记忆评估测试,并进行了双等位基因基因分型。这两个 SNP 的等位基因状态对任何记忆测试都没有影响。与 rs6439886 或 rs17070145 相比,没有增加任何类型的迟发性和认知障碍的风险。